Sutro Biopharma (STRO) Cash from Investing Activities (QoQ) (2018 - 2025)
Sutro Biopharma (STRO) Cash from Investing Activities (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 205.22 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.23% |
| Sep 30, 2025 | 1,449.96% |
| Jun 30, 2025 | 115.87% |
| Mar 31, 2025 | -118.58% |
| Dec 31, 2024 | -40.60% |
| Sep 30, 2024 | 283.25% |
| Jun 30, 2024 | -225.38% |
| Mar 31, 2024 | 372.64% |
| Dec 31, 2023 | 79.38% |
| Sep 30, 2023 | -272.35% |
| Jun 30, 2023 | -1.92% |
| Mar 31, 2023 | 278.06% |
| Dec 31, 2022 | 51.46% |
| Sep 30, 2022 | -262.87% |
| Jun 30, 2022 | 45.28% |
| Mar 31, 2022 | 58.71% |
| Dec 31, 2021 | 1,026.90% |
| Sep 30, 2021 | -138.16% |
| Jun 30, 2021 | 104.83% |
| Mar 31, 2021 | -870.10% |